Ionis Pharmaceuticals, Inc.
Oligomer-conjugate complexes and their use
Last updated:
Abstract:
Oligonucleotides, chemically-modified oligonucleotides, and oligonucleotide-conjugate complexes for use in research, diagnostics, and/or therapeutics are described herein. In some embodiments, oligonucleotides comprising a stabilized phosphate moiety covalently attached to the 5'-terminal nucleoside are provided.
Status:
Grant
Type:
Utility
Filling date:
18 Jun 2018
Issue date:
31 Aug 2021